Mefloquine Pellets

(Product under development)
Mefloquine Pellets Mefloquine hydrochloride (also known as Lariam or Mefaquin) is an orally administered medication used in the prevention and treatment of malaria.

Mefloquine was developed in the 1970s at the United States Department of Defense's Walter Reed Army Institute of Research as a synthetic analogue of quinine.

In August 2009, Roche stopped marketing Lariam in the United States.

Generic mefloquine from other manufacturers, is still widely available. Rare but serious neuropsychiatric problems have been associated with its use.

Available Form:
Mefloquine Pellets
Mefloquine Granules

Umang Pharmatech equipments used for production of Mefloquine Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Mefloquine Pellets
Systematic (IUPAC) Name
Mefloquine Pellets
Mefloquine Pellets
Chemical data
CAS number : 53230-10-7
ATC code : P01BC02
PubChem : CID 40692
DrugBank : DB00358
ChemSpider : 37171
UNII : TML814419R
KEGG : D04895
Formula : C17H16F6N2O
Mol. mass : 378.312 g/mol

* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech